Nationality
Canadian and American

Year of Birth
1958

• M.D. - Queen’s University, 1983 (Kingston, Canada)

• M.Sc. - California Institute of Technology, Biology, 1989 (Pasadena, USA)

• Ph.D. - University of California, San Francisco, Neuroscience, 1994 (San Francisco, USA)

• Postdoctoral fellow - Stanford University, Biochemistry, 1994-1998 (Stanford, USA)

1984-1987
Harvard Medical School (Boston, USA), Resident in Neurology

1987
Harvard Medical School (Boston, USA), Chief Resident in Neurology

1989-1998
University of California, San Francisco (San Francisco, USA), Adjunct Clinical Appointment in the Department of Neurology

1997-2006
Co-founder, President and CEO of Cytokinetics

2008-2010
President and CEO of Arete Therapeutics

2010-2013
Global Head and Vice President of Genentech Partnering, USA

2013-2018
Global Head and Senior Vice President of Genentech Partnering, USA

2018
Global Head of Pharma Partnering, Roche Basel, Switzerland

Since 1998
Member of Scientific Advisory Board at Cytokinetics

2007-2008
Executive Chairman of the Board of Directors of Cytokinetics

2008-2010
Chairman of the Board of Directors of Cytokinetics

2005-2016
Member of the Board of Directors of HopeLab

2015-2016
Member of the Board of Directors of California Life Sciences Association

2016-2020
Member of the Board of Directors of Coalition for the Life Sciences

since April 2019
Member of the Board of Directors of Chugai Pharmaceutical Co., Ltd.